Evogene Ltd.
EVGN
$0.97
-$0.0255-2.56%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -23.88M | -20.28M | -20.28M |
| Total Depreciation and Amortization | -- | -- | 2.61M | 2.59M | 2.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 90.00K | 398.00K | 398.00K |
| Change in Net Operating Assets | -- | -- | -400.00K | -621.00K | -621.00K |
| Cash from Operations | -- | -- | -21.58M | -17.91M | -17.91M |
| Capital Expenditure | -- | -- | -785.00K | -898.00K | -898.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 26.00K | 26.00K | 26.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -3.78M | -3.53M | -3.53M |
| Cash from Investing | -- | -- | -4.54M | -4.40M | -4.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -836.00K | -1.06M | -1.06M |
| Issuance of Common Stock | -- | -- | 8.45M | 8.43M | 8.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 10.54M | 10.58M | 10.58M |
| Cash from Financing | -- | -- | 18.15M | 17.94M | 17.94M |
| Foreign Exchange rate Adjustments | -- | -- | -245.00K | -164.00K | -164.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -8.21M | -4.53M | -4.53M |